BioRay Pharmaceuticals is based in Taizhou, Zhejiang, China. It has raised $369M in total funding. Latest round: Growth. Backed by PAG.
BioRay Pharmaceuticals funding overview
BioRay Pharmaceuticals is based in Taizhou, Zhejiang, China. BioRay Pharmaceuticals has raised $369M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2023. The round record for BioRay Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include PAG.
BioRay Pharmaceuticals at a glance
Total raised
$369M
Latest round
Growth
Latest round date
January 2023
Headquarters
Taizhou, Zhejiang, China
Notable investors
PAG
Frequently asked about BioRay Pharmaceuticals funding
How much has BioRay Pharmaceuticals raised?
BioRay Pharmaceuticals has raised $369M in total disclosed funding across the rounds on record.
Who has invested in BioRay Pharmaceuticals?
PAG are named among the investors backing BioRay Pharmaceuticals.
What was the latest BioRay Pharmaceuticals funding round?
The most recent disclosed round is a Growth, announced in January 2023.
Where is BioRay Pharmaceuticals based?
BioRay Pharmaceuticals is based in Taizhou, Zhejiang, China.
When did BioRay Pharmaceuticals last raise?
The last disclosed BioRay Pharmaceuticals round closed in January 2023 at Growth.
BioRay Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Taizhou below to benchmark round size and investor mix.
